Michael Kavanaugh

Dr. Kavanaugh currently serves as an associate clinical professor of medicine at UCSF and on the Scientific Advisory Boards of multiple biotech companies. Most recently, he was senior vice president, chief scientific officer, and head of research and early development at CytomX Therapeutics. Prior to joining CytomX, Dr. Kavanaugh was senior vice president and chief scientific officer of Five Prime Therapeutics, vice president of Novartis Vaccines & Diagnostics, Inc., Executive Director of Oncology Biologics in the Novartis Institutes of Biomedical Research, and vice president and head of antibody and protein therapeutics research at Chiron Corporation. Dr. Kavanaugh received his medical doctorate from Vanderbilt University and his bachelor’s degree in molecular biochemistry and biophysics from Yale University. He completed training in internal medicine, cardiovascular disease, and molecular and cellular biology at the University of California, San Francisco and the Cardiovascular Research Institute.